InvestorsHub Logo

Hopefull17

06/06/18 10:17 AM

#49997 RE: loanranger #49996

The share price is the answer - IMO, this is part of the CON and a distraction from the real issue - The ineptness of Berman (and Plutonium's influence) when it comes to actual marketing and execution. SAD - credibility and opportunity LOST! Investor Fraud Class Action exposure once and if any recovery from suit case against JnJ UNLESS a miracle by DEFAULT or in spite of Berman occurs, IMO.

Only Hillary has more excuses for failure! LMAO!

DrZem

06/06/18 11:42 AM

#49999 RE: loanranger #49996

I suspect the principal concern is margin erosion

nonsequetor

06/06/18 11:57 AM

#50001 RE: loanranger #49996

Are you SURE that the reticence to place GenUltimate! on store shelves is DECN's and not Walmart's?



Why would I be sure?

Your quoted statement was made by a company official in the last quarterly report.

"We remain reticent to place GenUltimate! on store shelves because of Walmart’s in-house pricing philosophy ($8.99 to $9.99 per retail box of test strips), which could and probably would ripple through the entire retail marketplace (on-line and in-store sales) lowering average retail prices throughout."



Questions regarding company statements should be directed to the company.

Decision Diagnostics
Ph: 805-446-1973
Fax: 805-446-1983
Email: info@decisiondiagnostics.com